Iloperidone Uses, Dosage, Side Effects and Interactions
Fanapt
Fanapt was the first iloperidone product the FDA approved, in May 2009. The FDA rates no generic as a substitute for it.
Iloperidone is an atypical antipsychotic used to treat schizophrenia in adults, and (for the Fanapt brand) the acute treatment of manic or mixed episodes of bipolar I disorder in adults.
Quick links
Ask Anything About IloperidoneType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Iloperidone in Short
- Drug class Atypical Antipsychotic How the FDA classifies it
What it treatsIloperidone is an atypical antipsychotic. It is used to treat schizophrenia in adults. The brand Fanapt is also approved for the acute treatment of manic or mixed episodes linked to bipolar I disorder in adults. The generic Iloperidone tablets in the label evidence are listed for schizophrenia only.
- How you get it Prescription only
- Comes asTablet (by mouth)Available strengths
- 1 mg
- 2 mg
- 4 mg
- 6 mg
- 8 mg
- 10 mg
See forms and strengths+ 1 more strengthShow fewer strengths
- 12 mg
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- What pharmacies pay
- Fanapt (brand)$30.49 to $60.04 a tablet
- Generic versionFDA-approved, not sold yet Pharmacies buy only the brand for now; see the expected launch below
- Generic launchNovember 2027 Our estimate for the first generic of Fanapt
The Pharmacist’s Take
Iloperidone (Fanapt) is an atypical antipsychotic for schizophrenia in adults (the Fanapt brand is also approved for manic or mixed episodes of bipolar I disorder) that likely works by blocking dopamine and serotonin receptors in the brain; on the market since about 2009, with FDA-approved generics listed, it is prescribed less often than the better-known options in its class. It is generally fairly well tolerated, but dizziness on standing, sleepiness, dry mouth, a stuffy nose and some weight gain are what people notice most. Its boxed warning is a higher risk of death in older adults with dementia-related psychosis, and because it can affect heart rhythm, fainting or palpitations need prompt attention.
Key Takeaways From the HelloPharmacist Team
- Take it twice a day, with or without food, following the gradual start exactly to avoid dizziness from blood pressure drops.
- If you have been off it for more than 3 days, call your prescriber before restarting, because the gradual build-up usually starts over.
- Some antidepressants like fluoxetine or paroxetine, and antibiotics like clarithromycin, raise its levels enough that the dose is usually cut in half.
- Get help right away for fever with severe muscle stiffness, and report any uncontrollable face, tongue or body movements.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Iloperidone.
Older adults with dementia-related psychosis who take antipsychotic medicines like iloperidone have a higher risk of death. Iloperidone is not approved to treat dementia-related psychosis.
In studies, most deaths appeared to be heart-related (such as heart failure or sudden death) or infections (such as pneumonia). If you care for someone with dementia who takes this medicine, talk to their prescriber before making any changes.
Patient Information Guide for Iloperidone
What It’s Used For
Iloperidone is an atypical antipsychotic used in adults for these conditions:
- Schizophrenia in adults (Fanapt and Iloperidone tablets)
- Acute treatment of manic or mixed episodes of bipolar I disorder in adults (Fanapt only)
How It Works
The exact way iloperidone works is unknown. It may act by blocking dopamine type 2 and serotonin type 2 receptors in the brain. Its active byproduct, P88, binds to receptors in a similar way.
Drug Class
Drug Class
- Atypical Antipsychotic
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Atypical Antipsychotic
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Iloperidone in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Iloperidone in the FDA’s index.
From our Patient Information GuideThe exact way iloperidone works is unknown. It may act by blocking dopamine type 2 and serotonin type 2 receptors in the brain. Its active byproduct, P88, binds to receptors in a similar way. Read How Iloperidone Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Iloperidone in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Other antipsychotics
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Iloperidone tablets are taken by mouth twice a day, with or without food. The dose is raised gradually to help prevent dizziness from low blood pressure when standing.
- Fanapt has separate schedules for schizophrenia and bipolar I disorder.
- People known to be CYP2D6 poor metabolizers use a lower dose.
- If you have been off the medicine for more than 3 days, the build-up is generally started again.
Follow your prescriber and label directions.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Schizophrenia
Adults · Days 1 to 7 titration, then recommended dose Starting dose 1 mg twice a day Usual dose 6 mg to 12 mg twice a day
Step by step
- 1 mg twice daily
- 2 mg twice daily
- 4 mg twice daily
- 6 mg twice daily
- 8 mg twice daily
- 10 mg twice daily
- 12 mg twice daily
- Recommended dosage 6 mg to 12 mg twice daily
Good to know
Titrate to avoid orthostatic hypotension; can be taken with or without food
Adults who are CYP2D6 poor metabolizers · Days 1 to 4 titration, then recommended dose Starting dose 1 mg twice a day Usual dose 3 mg to 6 mg twice a day
Step by step
- 1 mg twice daily
- 2 mg twice daily
- 4 mg twice daily
- 6 mg twice daily
- Titration complete
- Recommended dosage 3 mg to 6 mg twice daily
Good to know
Dose reduced by one-half for CYP2D6 poor metabolizers
Manic or mixed episodes of bipolar I disorder
Adults · Days 1 to 5 titration, then recommended dose Starting dose 1 mg twice a day Usual dose 12 mg twice a day
Step by step
- 1 mg twice daily
- 3 mg twice daily
- 6 mg twice daily
- 9 mg twice daily
- 12 mg twice daily
- Day 6 and 7: titration complete
- Recommended dosage 12 mg twice daily
Good to know
Titrate to avoid orthostatic hypotension
Adults who are CYP2D6 poor metabolizers · Days 1 to 3 titration, then recommended dose Starting dose 1 mg twice a day Usual dose 6 mg twice a day
Step by step
- 1 mg twice daily
- 3 mg twice daily
- 6 mg twice daily
- Titration complete
- Recommended dosage 6 mg twice daily
Good to know
Dose reduced by one-half for CYP2D6 poor metabolizers
Side Effects
The most common side effects seen in studies include:
Common side effects
- Dizziness
- Dry mouth
- Tiredness or fatigue
- Sleepiness (somnolence)
- Stuffy nose (nasal congestion)
- Fast heartbeat (tachycardia)
- Weight gain
- Low blood pressure when standing up
When to get medical help
- Call your doctor right away if you have fever, severe muscle stiffness, confusion, sweating, or an irregular pulse. These can be signs of neuroleptic malignant syndrome, which can be life-threatening.
- Get help if you feel dizzy, have palpitations, or faint. These can signal a heart rhythm problem.
- Tell your doctor if you notice uncontrollable movements of the face, tongue or body (tardive dyskinesia).
- Get help for signs of a severe allergic reaction, such as swelling of the face or throat or trouble breathing.
- Seek emergency care for a painful erection that will not go away (priapism).
- Report very high blood sugar signs, or signs of infection like fever, since low white blood cell counts can occur.
- Tell your doctor about a seizure.
- Call your doctor about fainting or a fall.
In bipolar mania studies, increased liver enzymes and low blood pressure were also common. Get medical help for fainting, a racing or irregular heartbeat, fever with stiffness, a prolonged painful erection, seizures, or severe allergic reactions.
Warnings and Precautions
- Higher risk of death in older adults with dementia-related psychosis. It is not approved for this use. Stroke risk is also a concern.
- QT prolongation. It can affect heart rhythm. Avoid with other QT-prolonging drugs and with certain heart conditions.
- Neuroleptic malignant syndrome. A rare, potentially fatal reaction.
- Tardive dyskinesia. Involuntary movements that may be permanent.
- Metabolic changes. High blood sugar, cholesterol changes and weight gain.
- Low blood pressure and fainting. Falls are also possible.
- Low white blood cell counts, seizures, priapism and impaired thinking or movement.
Interactions
Several drug combinations require caution or dose changes:
- Fluoxetine or paroxetine (strong CYP2D6 inhibitors) raise iloperidone levels, so the dose is halved.
- Ketoconazole or clarithromycin (strong CYP3A4 inhibitors) raise levels, so the dose is halved.
- Other QT-prolonging drugs add to the risk of heart rhythm problems.
- Blood pressure medicines can cause symptomatic low blood pressure; alpha-blockers should be avoided.
Interactions Listed in the FDA-Approved Label
From the Iloperidone prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Strong CYP2D6 inhibitors For example: fluoxetine or paroxetineWhat happensFluoxetine increased iloperidone and P88 exposure by about 2- to 3-fold and decreased P95 AUC by one-half; paroxetine increased mean steady-state peak concentrations of iloperidone and P88 by about 1.6-fold and decreased P95 by one-half.What to doReduce the iloperidone dose by one-half; when the inhibitor is withdrawn, return to the previous dose.
-
Strong CYP3A4 inhibitors For example: ketoconazole or clarithromycinWhat happensKetoconazole increased the AUC of iloperidone and its metabolites P88 and P95 by 57%, 55%, and 35%, respectively.What to doReduce the iloperidone dose by one-half; when the inhibitor is withdrawn, return to the previous dose.
-
Both strong CYP2D6 and strong CYP3A4 inhibitorsWhat happensCoadministration with inhibitors of both did not add to the effect of either inhibitor given alone.What to doReduce the iloperidone dose by about one-half, same as with one inhibitor; when withdrawn, return to the previous dose.
-
Drugs that prolong the QT intervalWhat happensMay add to the QT effects of iloperidone and increase the risk of cardiac arrhythmia.What to doAvoid use in combination with other drugs that prolong the QT interval.
-
Drugs that lower blood pressure For example: alpha-adrenergic blocking agentsWhat happensCould potentially cause symptomatic hypotension.What to doAvoid coadministration with alpha-adrenergic blocking agents and adjust medications that affect blood pressure as needed.
Read the label’s full interactions text
7 DRUG INTERACTIONS The dose of Iloperidone Tablets should be reduced in patients co-administered a strong CYP2D6 or CYP3A4 inhibitor. 7.1 Clinically Important Drug Interactions with Iloperidone Table 7 presents clinically important drug interactions with Iloperidone. Table 7: Clinically Important Drug Interactions with Iloperidone Strong CYP2D6 Inhibitors Clinical Impact Coadministration of fluoxetine with iloperidone increased exposure (area under curve, [AUC]) of iloperidone and its metabolite P88, by about 2- to 3- fold, and decreased the AUC of its metabolite P95 by one-half. Coadministration of paroxetine with iloperidone resulted in increased mean steady- state peak concentrations of iloperidone and its metabolite P88, by about 1.6- fold, and decreased mean steady-state peak concentrations of its metabolite P95 by one-half. Intervention Reduce the dose of iloperidone by one-half when administered with strong CYP2D6 inhibitors. When a strong CYP2D6 inhibitor is withdrawn from the combination therapy, the iloperidone dose should be returned to the previous level. Strong CYP3A4 Inhibitors Clinical Impact Co-administration of ketoconazole with iloperidone, increased the AUC of iloperidone and its metabolites P88 and P95 by 57%, 55%, and 35%, respectively. Intervention Reduce the dose of iloperidone by one-half when administered with strong CYP3A4 inhibitors. When the CYP3A4 inhibitor is withdrawn from the combination therapy, the iloperidone dose should be returned to the previous level.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use if you are allergic to iloperidone or its ingredients.
- Tell your doctor about heart rhythm problems, a recent heart attack, or heart failure.
- Mention seizures, diabetes, low white blood cell counts or low potassium or magnesium.
- Pregnancy: newborns exposed in late pregnancy may have movement or withdrawal symptoms.
- Breastfeeding: the label advises against it.
- Children: safety and effectiveness have not been established.
- Older adults: studies included few people 65 or older; the dementia warning applies.
- Liver: not recommended in severe impairment; moderate impairment may need a lower dose.
Overdose
Overdose can cause drowsiness, sedation, fast heartbeat and low blood pressure. There is no specific antidote, so care focuses on supportive treatment and heart monitoring. Contact Poison Help (1-800-222-1222) or seek emergency care.
Half-Life and How Your Body Processes It
The tablet is well absorbed, with peak levels in 2 to 4 hours. Food does not significantly change how much is absorbed. Steady levels are reached in 3 to 4 days.
The liver breaks it down mainly using CYP2D6 and CYP3A4. Half-life is about 18 hours in typical metabolizers and 33 hours in CYP2D6 poor metabolizers. Most of it leaves through urine and feces.
Storage
Store FANAPT tablets at controlled room temperature, 25℃ (77℉); excursions permitted to 15° to 30 ℃ (59° to 86℉) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Iloperidone: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Iloperidone — the kind of thing our pharmacy team would talk through with you at the counter.
What is iloperidone used for?
How do I take it?
What side effects should I expect?
When should I call my doctor right away?
Can I take it with my other medicines?
Is it safe in pregnancy or while breastfeeding?
Is iloperidone available over the counter?
When was iloperidone first available?
Who makes iloperidone?
What is the brand name of iloperidone?
What is the generic name of Fanapt?
What drug class is iloperidone?
Is there a generic version of iloperidone?
What strengths does iloperidone come in?
How much does iloperidone cost?
Is there a iloperidone shortage?
Where can I read the iloperidone prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Iloperidone
Skip the scrolling. Ask in your own words and get an answer from Iloperidone’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Iloperidone’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Iloperidone on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Iloperidone Forms and Strengths (How It Comes)
Iloperidone comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Iloperidone inactive ingredients by manufacturer.
Tablet
How this form is used
- Fanapt tablets are used for schizophrenia in adults.
- Fanapt is also used for acute manic or mixed episodes of bipolar I disorder in adults.
- Iloperidone tablets are used for schizophrenia in adults.
- Fanapt is taken by mouth twice daily, with or without food.
- Fanapt dosing is built up gradually, with a separate schedule for schizophrenia and bipolar I disorder.
- Iloperidone tablets are taken by mouth twice daily, with or without food, with gradual build-up of the dose.
Show 1 more strength Show fewer strengths
Iloperidone on the U.S. Market: Products, Makers and Brands
How Iloperidone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
2 companies list 24 Iloperidone product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2009. The one brand name in the directory today is Fanapt; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (8) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Iloperidone Is Used (Medicaid Data)
How many Iloperidone prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Iloperidone prescribed? Of the 1,682 medications we measure, Iloperidone ranks #738 by Medicaid prescriptions — more than 56% of them.
Utilization by Iloperidone product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
iloperidone 6 MG Oral Tablet Most dispensed
1 of 6 listed NDCs had Medicaid claims. RxNorm 848744
iloperidone 12 MG Oral Tablet
1 of 5 listed NDCs had Medicaid claims. RxNorm 848732
iloperidone 8 MG Oral Tablet
1 of 6 listed NDCs had Medicaid claims. RxNorm 848748
iloperidone 4 MG Oral Tablet
1 of 5 listed NDCs had Medicaid claims. RxNorm 848740
iloperidone 2 MG Oral Tablet
1 of 6 listed NDCs had Medicaid claims. RxNorm 848736
iloperidone 1 MG Oral Tablet
1 of 6 listed NDCs had Medicaid claims. RxNorm 848722
iloperidone 10 MG Oral Tablet
1 of 5 listed NDCs had Medicaid claims. RxNorm 848728
Other Iloperidone products: packs and listings not matched to one strength and form
1 of 19 listed NDCs had Medicaid claims.
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 8 of the 58 listed Iloperidone NDCs had Medicaid claims.
Compare Iloperidone Products
A representative set of FDA-listed product records for Iloperidone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 1 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 2 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 4 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 6 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 8 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 10 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 12 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 1 mg | Oral | Vanda Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| 2 mg | Oral | Vanda Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| 4 mg | Oral | Vanda Pharmaceuticals Inc. | NDA | View NDC → |
| 6 mg | Oral | Vanda Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| 8 mg | Oral | Vanda Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| 10 mg | Oral | Vanda Pharmaceuticals Inc. | NDA | View NDC → |
| 12 mg | Oral | Vanda Pharmaceuticals Inc. | NDA | View NDC → |
| 💊Kits | ||||
| — | Oral | Vanda Pharmaceuticals Inc. × 6 listings | NDA | View NDC → |
Showing 24 of 24 products — FDA National Drug Code Directory. See every product, package size and price: browse all 24 Iloperidone NDCs →
Iloperidone Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Iloperidone — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Iloperidone are dizziness, insomnia, weight increased; about 49% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Iloperidone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Iloperidone FDA Approval History
How Iloperidone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Iloperidone was first approved by the FDA in 2009 (Brand: FANAPT · Vanda Pharms Inc); the first generic version was approved in 2016. It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Iloperidone Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Iloperidone recalls since July 2021.
✅No Iloperidone recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Iloperidone in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 1
- Strengths
- 7
- Forms in current FDA listings
- 1 of 1
RxCUI 73178 RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Iloperidone Supply and Shortage Status
Whether Iloperidone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Iloperidone Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Iloperidone: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a strength to see how its price has changed since Nov 2023.
For brand-name Fanapt, the 4 mg tablet, pharmacies paid an average of $30.50 per tablet as of Nov 18, 2026, up 4.1% from $29.29 a year earlier.
- What pharmacies pay now
- $30.50
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- No change
- from $30.51 on Oct 21, 2026
- Last 12 months
- Up 4.1%
- from $29.29 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $27.74 to $30.53
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $30.50 |
| Oct 2026 | $30.51 |
| Sep 2026 | $30.53 |
| Aug 2026 | $30.51 |
| Jul 2026 | $30.44 |
| Jun 2026 | $30.50 |
| May 2026 | $30.46 |
| Apr 2026 | $30.46 |
| Mar 2026 | $30.46 |
| Feb 2026 | $30.46 |
| Jan 2026 | $29.29 |
| Dec 2025 | $29.29 |
| Nov 2025 | $29.29 |
| Oct 2025 | $29.23 |
| Sep 2025 | $29.22 |
| Aug 2025 | $29.17 |
| Jul 2025 | $29.16 |
| Jun 2025 | $29.15 |
| May 2025 | $29.33 |
| Apr 2025 | $29.33 |
| Mar 2025 | $29.33 |
| Feb 2025 | $29.33 |
| Jan 2025 | $28.48 |
| Dec 2024 | $28.49 |
| Nov 2024 | $28.49 |
| Oct 2024 | $28.49 |
| Sep 2024 | $28.48 |
| Aug 2024 | $28.57 |
| Jul 2024 | $28.43 |
| Jun 2024 | $28.45 |
| May 2024 | $28.58 |
| Apr 2024 | $28.29 |
| Mar 2024 | $28.29 |
| Feb 2024 | $28.29 |
| Jan 2024 | $28.29 |
| Dec 2023 | $27.74 |
| Nov 2023 | $27.74 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Tablet · Oral | 1 mg | Fanapt (brand) | $30.49 per tablet | NDC details & price history |
| Tablet · Oral | 4 mg | Fanapt (brand) | $30.50 per tablet | NDC details & price history |
| Tablet · Oral | 6 mg | Fanapt (brand) | $37.60 per tablet | NDC details & price history |
| Tablet · Oral | 8 mg | Fanapt (brand) | $37.53 per tablet | NDC details & price history |
| Tablet · Oral | 10 mg | Fanapt (brand) | $60.04 per tablet | NDC details & price history |
| Tablet · Oral | 12 mg | Fanapt (brand) | $59.88 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Iloperidone Brand Names
Iloperidone has one brand name on record: Fanapt. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Iloperidone: Manufacturers and Labelers
2 companies list Iloperidone products with the FDA. By number of product records, the largest are Vanda Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Iloperidone Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Vanda Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →